The American Seed Trade Association (ASTA) is pleased with the clarification made by USDA last week regarding oversight of plants produced through innovative new breeding techniques, including gene editing.
“The (USDA) announcement really clarifies the practice they’ve had had ongoing for the last couple of years in that products created through gene editing don’t need to go through pre-market, regulatory process that transgenic and biotech products do,” said ASTA president and CEO Andy LaVigne.
Learn more in this interview. Interview with ASTA CEO Andy LaVigne